Publication | Open Access

Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders

Microdose CyclesInfertilityDevelopmental BiologyFertilityPoor RespondersOvulation InductionGynecologyReproductive MedicineReproductive BiologyPublic HealthEndocrinologyMedicineReproductive HormoneHuman Reproduction